# Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

> **NCT06961526** · NA · RECRUITING · sponsor: **Tanta University** · enrollment: 110 (estimated)

## Conditions studied

- Esophageal and/or Gastric Varices
- Hepatocellular Carcinoma (HCC)

## Interventions

- **PROCEDURE:** Esophageal band ligation

## Key facts

- **NCT ID:** NCT06961526
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06961526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06961526, "Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06961526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*